++
+++
Essentials of Diagnosis
++
Sweating, weight loss or gain, anxiety, palpitations, loose stools, heat intolerance, menstrual irregularity
Tachycardia; warm, moist skin; stare; tremor
Graves disease
Amiodarone: most common cause of thyrotoxic crisis ("thyroid storm")
Suppressed TSH in primary hyperthyroidism; usually increased T4, FT4, T3, FT3
+++
General Considerations
++
Most common cause of thyrotoxicosis
An autoimmune disorder, characterized by an increase in synthesis and release of thyroid hormones
More common in women than in men (8:1)
Onset usually between the ages of 20 and 40 years
May be accompanied by infiltrative ophthalmopathy (Graves exophthalmos) and, less commonly, by infiltrative dermopathy (pretibial myxedema)
Patients with Graves disease have an increased risk of other systemic autoimmune disorders, including
Sjögren syndrome
Celiac disease
Pernicious anemia
Addison disease
Alopecia areata
Vitiligo
Type 1 diabetes mellitus
Hypoparathyroidism
Myasthenia gravis
Cardiomyopathy
+++
Toxic multinodular goiter and thyroid nodules
++
Autonomous hyperfunctioning thyroid nodules that produce hyperthyroidism are known as toxic multinodular goiter (Plummer disease); a single hyperfunctioning nodule can also produce hyperthyroidism
More prevalent among older adults and in iodine-deficient regions
Toxic multinodular goiter and Graves disease may sometimes coexist in the same gland (Marine-Lenhart syndrome)
Thyroid cancer is found in about 5% of patients with toxic multinodular goiter
++
These conditions cause thyroid inflammation which may release stored hormone
Autoimmune thyroiditis (Hashimoto, postpartum thyroiditis, painless sporadic subacute thyroiditis), painful subacute thyroiditis, infectious thyroiditis, and IgG4-related thyroiditis are detailed in Thyroiditis
+++
Amiodarone-induced hyperthyroidism
++
The leading cause for thyrotoxic crisis ("thyroid storm")
Causes thyrotoxicosis in about 3% of patients in the United States
Induces thyrotoxicosis in about 20% of patients in Europe and iodine-deficient geographic areas
Thyrotoxicosis can occur at any time during treatment and may even develop several months after treatment discontinuation
++
Heat intolerance, sweating
Palpitations
Pruritus
Frequent bowel movements
Weight loss (or gain)
Menstrual irregularities
Nervousness, fine resting tremor
Fatigue
Muscle weakness, muscle cramps, hyperreflexia
Thyroid in Graves disease
Eye
Upper eyelid retraction
Stare and lid lag with downward gaze
Thyroid associated ophthalmopathy (exophthalmos) in 20–40% of patients with Graves disease
Diplopia may be due to coexistent myasthenia gravis
Skin
Heart
Thyrotoxic crisis or ...